| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 508,100 | 461,800 | 450,000 | 479,300 | | Cost of Revenue | 104,400 | 95,000 | 98,600 | 106,100 | | | Gross Profit | 403,700 | 366,800 | 351,400 | 373,200 | | | Operating Expenses | | Research Development | 47,800 | 41,700 | 53,700 | 54,500 | | Selling General and Administrative | 199,000 | 181,800 | 180,500 | 180,400 | | Non Recurring | 1,000 | 500 | 1,000 | 9,600 | | Others | 8,300 | 8,000 | 8,000 | 8,400 | | | | Total Operating Expenses | 256,100 | 232,000 | 243,200 | 252,900 | | | | Operating Income or Loss | 147,600 | 134,800 | 108,200 | 120,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,200 | 3,100 | 4,800 | (2,900) | | Earnings Before Interest And Taxes | 151,800 | 137,900 | 113,000 | 117,400 | | Interest Expense | 5,100 | 5,300 | 5,500 | 3,300 | | Income Before Tax | 146,700 | 132,600 | 107,500 | 114,100 | | Income Tax Expense | 36,000 | 38,400 | 25,100 | 30,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 110,700 | 94,200 | 82,400 | 83,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 110,700 | 94,200 | 82,400 | 83,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $110,700 | $94,200 | $82,400 | $83,300 |
|
0.34% Nasdaq 
Income Statement
